A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients - Test2 - elhamkhani - TriplyDB

A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients

A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients

http://www.wikidata.org/entity/Q24652357

about

Genomics of adaptation during experimental evolution of the opportunistic pathogen Pseudomonas aeruginosa Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients Role of the gut microbiota in defining human health Cystic Fibrosis Lung Infections: Polymicrobial, Complex, and Hard to Treat Noisy neighbourhoods: quorum sensing in fungal-polymicrobial infections Innocent until proven guilty: mechanisms and roles of Streptococcus-Candida interactions in oral health and disease Crystal Structure of a Charge Engineered Human Lysozyme Having Enhanced Bactericidal Activity Global Analysis of the Fungal Microbiome in Cystic Fibrosis Patients Reveals Loss of Function of the Transcriptional Repressor Nrg1 as a Mechanism of Pathogen Adaptation The cystic fibrosis lower airways microbial metagenome How bioinformatics influences health informatics: usage of biomolecular sequences, expression profiles and automated microscopic image analyses for clinical needs and public health The airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic management Culture enriched molecular profiling of the cystic fibrosis airway microbiome Changes in cystic fibrosis airway microbial community associated with a severe decline in lung function.Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes.Evolutionary remodeling of global regulatory networks during long-term bacterial adaptation to human hosts.Determining cystic fibrosis-affected lung microbiology: comparison of spontaneous and serially induced sputum samples by use of terminal restriction fragment length polymorphism profiling.A modeling-derived hypothesis on chronicity in respiratory diseases: desensitized pathogen recognition secondary to hyperactive IRAK/TRAF6 signaling.The role of the bacterial microbiome in lung disease Characterization of Streptococcus milleri group isolates from expectorated sputum of adult patients with cystic fibrosis.Phylogenetic and metabolic diversity of bacteria associated with cystic fibrosis.Breath gas metabolites and bacterial metagenomes from cystic fibrosis airways indicate active pH neutral 2,3-butanedione fermentation.Polymicrobial airway bacterial communities in adult bronchiectasis patients.Influence of chronic azithromycin treatment on the composition of the oropharyngeal microbial community in patients with severe asthma It's not easy being green: the viridans group streptococci, with a focus on pediatric clinical manifestations Analysis of the bacterial communities present in lungs of patients with cystic fibrosis from American and British centers.Partitioning core and satellite taxa from within cystic fibrosis lung bacterial communities Development of real-time PCR assays for detection of the Streptococcus milleri group from cystic fibrosis clinical specimens by targeting the cpn60 and 16S rRNA genes Reliability of quantitative real-time PCR for bacterial detection in cystic fibrosis airway specimens Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infections Antibiotic management of lung infections in cystic fibrosis. II. Nontuberculous mycobacteria, anaerobic bacteria, and fungi Next-generation sequencing in the analysis of human microbiota: essential considerations for clinical application.The changing microbial epidemiology in cystic fibrosis.The metabolic footprint of the airway bacterial community in cystic fibrosis.The upper respiratory tract as a microbial source for pulmonary infections in cystic fibrosis. Parallels from island biogeography.Time between collection and storage significantly influences bacterial sequence composition in sputum samples from cystic fibrosis respiratory infections Pulmonary exacerbations in cystic fibrosis with negative bacterial cultures.Polymicrobial challenges to Koch's postulates: ecological lessons from the bacterial vaginosis and cystic fibrosis microbiomes.Bacterial diversity in oral samples of children in niger with acute noma, acute necrotizing gingivitis, and healthy controls.The role of the microbiome in exacerbations of chronic lung diseases.Decade-long bacterial community dynamics in cystic fibrosis airways.

P2860

Q21144908-2E2B2BC1-CA63-4D8B-99B4-33F43F5912E6 Q21562196-A2FEF6F9-8FF9-4501-AD5C-D51F487D717F Q24599062-54527B74-D7A9-422C-8EFD-8253E22B1BF1 Q26771468-901A7D43-8DD4-4C54-B4A0-D7C2F7758CD8 Q26799027-2CEAC690-399A-4AC0-AD08-4499F2D3A1AB Q26830891-1E030870-C2E0-429D-B39D-47E79BF1B8EE Q27667276-DE4A39BF-AB41-40E6-967C-08131000B7DB Q28551061-244EFE9C-4288-490B-BC8C-28EFFFB0E760 Q28596642-2D9C8B10-7FD2-473F-9F22-5ED6F24B7CC1 Q28649612-28434A85-9DFD-4A95-B310-B21E9037C08A Q28730299-A787EBC4-40E4-41B6-8CC9-E5B4C41D39A5 Q28742049-3AF21C01-ADB2-41E4-B4CF-895710A62B67 Q30388877-16047659-4EF6-48ED-9BE1-DBA9BB834FDE Q30426714-C2F14501-A77F-4F4A-9E46-46147CB2E2B5 Q30539692-810CD7B9-7E7D-410B-AAE2-EFD7D9C30F90 Q30882278-5E30AA58-C2EE-44F3-97B7-C7FCFC45F754 Q33434485-25ECB12D-7F6C-48A4-9E1D-5C4785447B56 Q33554623-E911E241-D3AE-4F8C-8DC5-1991AC86EB36 Q33627368-42F24C07-CA9C-45F3-AADA-CE5009A0D6C5 Q33633034-E502FEB9-CE3F-4732-9683-DFD973165DDB Q33647129-8BAECE23-97AA-43EF-98F3-32EFAFCF0350 Q33650443-6B5B7FBF-6537-4F4B-858F-4D8C446588A9 Q33655081-F9430961-98DE-48D9-8D33-94FB60FDB1D7 Q33681771-4FE35E34-9BDB-48B2-BC8C-F2DB890E62C7 Q33743766-0608777A-1E55-4ED5-BFFE-E799CD60F0D0 Q33768691-990D5746-4922-456C-B55F-C27B26212587 Q33769617-FC31952F-F239-4F8D-A44F-76B142F7D2E7 Q33770039-E2D6D45C-4C52-4D2E-88CB-5120D7436C93 Q33786154-13AB7D6C-0FEF-4681-B250-2A292FE3F54C Q33792765-C92E3FD5-202C-44D5-B792-3004CB83458E Q33806208-A4AB60D3-E671-4EE6-ABA2-3BDBBB9A0C27 Q33825634-C214C2DD-A47B-4D14-BA8C-78418A212D5C Q33861701-5E1EFAE6-FDAF-448C-A937-79992947691C Q33901596-58BDA41A-D2FC-431D-BA10-4A3B4E79960F Q34058611-FF3A3CBE-8568-4C44-A4B3-3B815E0B3BD8 Q34118967-2D2A9DFF-86C1-4593-B20D-CBAAB73EEC39 Q34179233-A54390FB-89F5-49D7-811C-B2AEBDB674A7 Q34193887-7671A78E-C7FC-4F0D-BDCB-B008126D75FE Q34199591-A76CC54C-3C4D-4BEF-AB08-71726CE4E599 Q34209009-B6CA3854-80E6-4887-BEEB-12C92FAED079

P2860

A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients

http://www.wikidata.org/entity/Q24652357

description

2008 nî lūn-bûn

@nan

2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

A polymicrobial perspective of ...... en in cystic fibrosis patients

@ast

A polymicrobial perspective of ...... en in cystic fibrosis patients

@en

A polymicrobial perspective of ...... en in cystic fibrosis patients

@nl

type

label

A polymicrobial perspective of ...... en in cystic fibrosis patients

@ast

A polymicrobial perspective of ...... en in cystic fibrosis patients

@en

A polymicrobial perspective of ...... en in cystic fibrosis patients

@nl

prefLabel

A polymicrobial perspective of ...... en in cystic fibrosis patients

@ast

A polymicrobial perspective of ...... en in cystic fibrosis patients

@en

A polymicrobial perspective of ...... en in cystic fibrosis patients

@nl

P1433

Q24652357-D3C16149-B6D1-4EB5-80B2-E3B6122BC5DA

P1476

Q24652357-E62C6C3A-0477-46E0-82F8-D3511EAAE2DE

P2093

Q24652357-44EB85EB-131A-41EE-BB51-D7F54938281B

Q24652357-5A14BF89-D184-49B6-A81B-F8A4D2641C88

Q24652357-71888CD0-30FE-4D50-94AB-02AF70D6BC01

Q24652357-9EE54C5D-1DB9-4753-BEB7-28D2E665B994

Q24652357-EEE578A3-FAE3-41D0-A92D-72E675C3CEA6

P2860

Q24652357-0318B417-F582-4285-855D-AD44E5FEF687

Q24652357-03CD2BE2-AE3B-41E1-BBFD-15580CB46D2C

Q24652357-05536011-8E23-4AF7-9930-634486D5A271

Q24652357-095C9FF2-A7E2-4B7A-BF7A-3C8BF43981B1

Q24652357-0A684E89-E42C-4BC2-A3FA-BB361B65754B

Q24652357-0AB53919-57C6-4D1E-82E7-8B54B4864467

Q24652357-1E39400D-610A-4091-8BFA-34C662A256FE

Q24652357-2220AC6F-FADF-4833-9F9D-387516280281

Q24652357-282103FC-0BA0-48CF-87E6-58E728762779

Q24652357-2C202660-17B1-49DC-9FF6-11325DD1F3FA

P304

Q24652357-7E37D0B3-251D-4714-98A4-4C30DA022694

P31

Q24652357-ECB59B15-E767-4925-88BB-2491F2114711

P3181

Q24652357-8E72CA78-3DAE-4484-9F98-08E64DEA5534

P356

Q24652357-8BB5502C-9753-4BEE-AD6E-CCFFADFFEEB7

P407

Q24652357-65148680-3A9A-4B66-92D1-BF43C6FEC58C

P433

Q24652357-724F1941-AB74-4D13-80FF-112C8D17A7A9

P478

Q24652357-A4B44321-A631-4918-97AB-FF74835F2010

P50

Q24652357-93544AFA-1815-4B26-A865-CC042D874013

P577

Q24652357-0994DDB8-696B-4620-BCC6-6E8AECF3688A

P5875

Q24652357-75EEF40F-C1BF-49DC-AE53-C28C61DEB1E4

P698

Q24652357-1F3C94C6-15E2-4C79-9DD6-4944640DBE1C

P921

Q24652357-34F3701D-560B-4BB1-AE41-375F4671FCBE

Q24652357-B3941FB8-86F3-4BF5-B57E-59E1C3871D42

P932

Q24652357-A17790C1-74DF-4B68-A320-FD075A725799

P3181

P356

PNAS.0804326105

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

A polymicrobial perspective of ...... en in cystic fibrosis patients

@en

P2093

Christopher D Sibley

http://www.w3.org/2001/XMLSchema#string

Harvey R Rabin

http://www.w3.org/2001/XMLSchema#string

Jens C Norgaard

http://www.w3.org/2001/XMLSchema#string

Michael D Parkins

http://www.w3.org/2001/XMLSchema#string

Michael G Surette

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease

Streptococcus anginosus ("Streptococcus milleri"): the unrecognized pathogen

Cluster analysis and display of genome-wide expression patterns

Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus (the Streptococcus milleri group): association with different body sites and clinical infections

Bacterial activity in cystic fibrosis lung infections.

Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis

Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients

Lung infections associated with cystic fibrosis.

Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication.

Web-based phylogenetic assignment tool for analysis of terminal restriction fragment length polymorphism profiles of microbial communities.

P304

15070-15075

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

409412

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.0804326105

http://www.w3.org/2001/XMLSchema#string

P407

P433

39

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-09-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23277536

http://www.w3.org/2001/XMLSchema#string

P698

18812504

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis

P932

2567494

http://www.w3.org/2001/XMLSchema#string